#venture capital

Lovable's $330M raise from Nvidia and Google at a $6.6B valuation isn't just a funding round. It's a strategic bet on the AI software factory. Here's why.

China's new $40B 'New Productive Forces' fund isn't just cash. It's a strategic shift to a state-guided venture model aimed at dominating future tech.

Chai Discovery's $1.3B valuation isn't just funding; it's a bet on 'Generative Biology.' Our analysis explores the impact on pharma R&D and investors.

Monzo's CEO ouster reveals a strategic pivot from a quick IPO to a long-term global expansion. Here's what it means for investors and the fintech landscape.

MoEngage's $180M funding isn't just another round. PRISM analyzes how its secondary-heavy deal signals a new, smarter playbook for late-stage tech startups.

Chai Discovery's $1.3B valuation isn't just a funding round. It's proof that AI is moving from chatbots to designing life, creating a new breed of AI-native biotech.

Swedish AI startup Lovable just tripled its valuation to $6.6B. Our analysis breaks down why this isn't just hype, but a fundamental shift in software development.

Chai Discovery's $130M raise at a $1.3B valuation isn't about a single drug. It's a strategic move by OpenAI's ecosystem to build the dominant AI platform for biotech.

Chai Discovery's $130M raise at a $1.3B valuation isn't about a single drug. It's a strategic move by OpenAI's ecosystem to build the dominant AI platform for biotech.

Last Energy's $100M raise signals a major shift in nuclear tech. Discover why their 'boring' 1960s reactor design could be the key to powering the AI boom.

Chai Discovery's $130M raise at a $1.3B valuation isn't a funding story. It's a signal that elite AI talent is targeting pharma's core business model.

Zoox co-founder Tim Kentley-Klay's new startup HyprLabs is challenging the 'big data' model of self-driving cars with a new, data-efficient AI approach.